Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
phantom, they might have to charge 5p for the bag
Yea
diversified do you mean sitting duck as in probable takeover
Think of the loss of earnings that could have been in place during the creation of an alternative alone.
The liquid biopsy sector is full of the big boys given the market opportunities ahead.
Which ever way you look at it, AGL are a sitting duck
I'm with Divers. Big pharma's can't be arsed taking years to copy it, missing out on revenue. Just buy it now.
Thank you sir £30, would you like a bag?
in firms like AGl how much money and time and effort are spent on the financial legalities ie copyright ,patent protection and infringement ?
I would say that given possible patent infringement, length of time to prove the concept whilst losing market share to the first mover, having the infrastructure in place and key opinion leading papers. It would be far easier to just buy out AGL.
Fascinating debates about RSI and TA. For me investing in this stock is more about it's exciting technology and it's disruptive potential!! But I do wonder how protected are there patents though, for example, how easy would it be for the likes of Thermal Fisher or Abbott or others to slightly tweak and improve their tech to make their product patent obsolete? But I guess, even if a competitor does that, they still would need a few years to register and get it to market I guess.. fingers crossed a product approval is confirmed and contracts fly in to verify the demand for this product.
think a lady godiva could come really suddenly if the right news compounds each other bit ,ie more clinical income ,fda ,nasdaq and hopefully tr1 from big entities buying AFTEr fda approval with sticky hands ,only 213 million shares and for a firm with such possible high it acerbates its potential shareprice .
just bough 817 more so when it shows its definetly a buy
Morning Res
I would respectfully disagree. Al stocks ultimately are news driven. it is exactly the breaking of news that gives stocks so much volatility leading to over sold and over bought reactions that the RSI flags up. But as always each to his own.
£15? How did u come to that?
on the other bb a d v f n sicilian kan has posted an exceptional post ,worth reading
Over the years I have traded using Sp.Bet, CFD, etc. Did well in the 2007/8 crash etc but the thing to remember is that 80-90% of retail traders lose money, traders rarely talk about losers only trumpet winners. Unless you are a professional, there is a tendency to run loses hoping for a turn and take profits too early frightened of it evaporating. Charts do paint a picture of course but more useful in hindsight, yes support and resistance points are obvious on charts but unless trading makes no odds. Over the past 20 years I have found the best way to make good returns in the market is to identify a company or two at the most that will either move from loss making to profit or have growth plans that you can convert into real earnings. Calculate realistic share prices over a future time period and buy blow your future valuation, If the company moves over your future valuation too early sell and wait for pull back to buy back in. Trading too often increases the risk of making an error and trades feel the need to be busy trading so often overtrade and wipe out previous gains.
Sight tight in AGL until it hits you own target , my target here is £15 FWIW. GLA
RSI systems are notoriously fallible when movement is news-driven however.....